NEXLETOL Gains Approval in Japan: A Major Global Expansion for Esperion

Esperion's cholesterol pill, NEXLETOL, is now approved in Japan through its partner, Otsuka. This major global expansion (now U.S., Europe, Japan) secures Esperion large milestone payments and tiered royalties (15%-30%) on sales.